SK Biopharmaceuticals Co., Ltd. 326030
KRX · South Korea · Health Technology
KRW 76,700.00+2,300.00 (+3.09%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 581.55 | 581.55 | 0.0% | KRW 247.40B | +1.9% | +4.6%KRW 79,800.00→KRW 83,500.00 |
| Q4 2025 | 2026-03-09 | 1,744.00 | 434.02 | +301.8% | — | — | -2.9%KRW 102,900.00→KRW 99,900.00 |
| Q4 2024 | 2025-03-07 | 2,428.00 | 197.19 | +1,131.3% | — | — | — |
| Q4 2023 | 2024-03-18 | 86.00 | 47.63 | +80.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.